-2.95 (-0.20%) Cipla’s wholly owned subsidiary - Cipla (EU), has entered into a definitive agreement with Biopharma SPA for establishing a joint venture company in Algeria.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.